British American Tobacco PLC (BTI)
|Net Income (ttm)||8.77B|
|Trading Day||July 29|
|Day's Range||37.93 - 38.34|
|52-Week Range||30.46 - 41.14|
British American Tobacco on Wednesday reported better-than-expected revenue for the first half of the year as the Lucky Strike cigarette maker added a record number of new customers for its vaping produ...
Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your P...
Smoking a cigarette is still a habit that many people will not give up easily. Pall Mall, Camel and Rothmans, which are all manufactured and sold by British American Tobacco PLC ( BTI , Financial), were...
If you want to invest in overseas markets, these seven top international stocks can help diversify your portfolio with more good returns. The post 7 Top International Stocks to Buy Today appeared first ...
A trading update tomorrow from British American Tobacco PLC (LON:BATS) may be given an extra spark due to the recent revelation that Kenneth Dart, the secretive billionaire investor, has built up a larg...
The fight's not over, but it could be a devastating blow.
Advocates Praise FDA Ban on Menthol Cigarettes
Filmmaker Lincoln Mondy, who partnered with Truth Initiative for the film 'Black Lives / Black Lungs,' joined Cheddar to discuss the importance of the FDA's decision to move to ban menthol cigarettes an...
The U.S. Food and Drug Administration (FDA) on Thursday agreed to a petition from more than a dozen public health and civil rights groups that could lead to a ban on menthol cigarettes and flavored ciga...
FDA moves forward with plan to ban menthol cigarettes and flavored cigars
Shep Smith reports on the FDA plan to move ahead with a plan to ban menthol-flavored cigarettes and flavored cigars.
FDA moves to ban menthol, flavored cigarettes
CNBC's Meg Tirrell reports on a proposed ban on menthol and flavored cigarettes.
FDA to ban menthol cigarettes this week
The FDA could ban menthol cigarettes as early as tomorrow. CNBC's Meg Tirrell joins 'The News with Shepard Smith' to report how this decision could impact the black community.
British American Tobacco PLC (LON:BATS) has reported constant currency revenue growth above its previous forecasts despite what it said was the “unprecedented impact of the global pandemic” on global li...
Tobacco's potential could get lost in the fog of a stricter regulatory climate.
Altria looks like an undervalued income stock, but it's a high-yield trap.
Markets were sharply lower on Wall Street.
Tobacco stocks like MO stock and PM stock are suffering Tuesday following reports that the FDA could cut nicotine levels in cigarettes. The post Tobacco Stocks: Why PM, IMBBY, BTI, MO Stocks Are Getting...
Imperial Brands PLC (LON:IMB) and British American Tobacco PLC (LON:BATS) tumbled today on a report that the US might order a reduction in the nicotine content in cigarettes. US authorities are consider...
News that a major new regulation may be coming for cigarette makers put investors on alert Monday afternoon.
The Biden administration is considering whether to cap nicotine levels in cigarettes, the Wall Street Journal reported.
Investors are happy with the company's progress diversifying away from tobacco and nicotine.
The deal is the latest in a string of recent arrangements between companies in "traditional" sectors and marijuana businesses.
If you are looking for high return investments, you could be interested in the three non-cyclical stocks listed below, as their earnings yields (as calculated via Joel Greenblatt (Trades, Portfolio)'s m...
Strategy and culture alignment: Organigram CEO on British American Tobacco partnership
Greg Engel, Organigram CEO, joins 'Power Lunch' to discuss why the Canadian cannabis company chose to partner with British American Tobacco and the future of the marijuana industry.
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...
Revenue is expected to sharply expand as well, leading to a doubling of the analysts' target price.
OrganiGram Holdings Inc's (NASDAQ: OGI) stock is likely to re-rate following the investment by a subsidiary of British American Tobacco PLC (NYSE: BTI), according to Cantor Fitzgerald. The OrganiGram An...
The cannabis grower and the tobacco giant will jointly develop new CBD-based consumer products.
OrganiGram is on the move today thanks to a new deal with British American Tobacco. Here's what to know about OGI stock now.
British American Tobacco said on Thursday it will buy a nearly 20% stake in Canada-based cannabis producer Organigram for about 126 million pounds ($175.81 million) as it diversifies beyond its main tob...
Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity I...
MONCTON, New Brunswick--(BUSINESS WIRE)---- $OGI--Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI) is pleased to announce a C$221 million strategic investment from a wholly-owned subsidiary of...
As of March 9, the GuruFocus All-in-One Screener, a Premium feature, found that the following guru-owned defensive stocks have low price-earnings ratios. While some of them are great value investments, ...
And it might come out on top because of it.
British American Tobacco is looking at selling more cannabis products as it seeks to find new sources of revenue beyond cigarettes.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
|Stock Exchange |
|Ticker Symbol |
In 2020, BTI's revenue was 25.78 billion, a decrease of -0.39% compared to the previous year's 25.88 billion. Earnings were 6.40 billion, an increase of 12.20%.
According to 4 analysts, the average rating for BTI stock is "Buy." The 12-month stock price forecast is 50.56, which is an increase of 32.46% from the latest price.